Vincent Andrews
Stock Analyst at Morgan Stanley
(4.81)
# 70
Out of 4,842 analysts
316
Total ratings
66.99%
Success rate
26.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Vincent Andrews
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CC The Chemours Company | Maintains: Equal-Weight | $22 → $15 | $9.93 | +51.06% | 16 | May 12, 2025 | |
| CTVA Corteva | Maintains: Overweight | $65 → $71 | $69.50 | +2.16% | 12 | May 9, 2025 | |
| AXTA Axalta Coating Systems | Maintains: Equal-Weight | $40 → $36 | $30.99 | +16.17% | 10 | May 8, 2025 | |
| ALB Albemarle | Maintains: Underweight | $68 → $58 | $56.97 | +1.81% | 13 | May 6, 2025 | |
| TROX Tronox Holdings | Maintains: Equal-Weight | $12 → $8 | $4.87 | +64.44% | 12 | May 5, 2025 | |
| DD DuPont de Nemours | Maintains: Equal-Weight | $94 → $80 | $68.19 | +17.32% | 10 | May 5, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $125 → $115 | $80.65 | +42.59% | 15 | Apr 28, 2025 | |
| SHW The Sherwin-Williams Company | Maintains: Overweight | $405 → $385 | $353.31 | +8.97% | 24 | Apr 22, 2025 | |
| CF CF Industries Holdings | Maintains: Equal-Weight | $85 → $80 | $89.30 | -10.41% | 18 | Apr 11, 2025 | |
| BG Bunge Global | Maintains: Equal-Weight | $90 → $74 | $78.66 | -5.92% | 12 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $52 → $47 | $48.02 | -2.12% | 18 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $46 | $39.34 | +16.93% | 15 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $85 | $56.91 | +49.36% | 10 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $46 → $43 | $28.27 | +52.10% | 16 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $263 → $280 | $262.50 | +6.67% | 15 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $80 | $53.42 | +49.76% | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $240 → $280 | $269.97 | +3.72% | 13 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $420 | $461.04 | -8.90% | 9 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $155 | $110.20 | +40.65% | 16 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $91 | $58.95 | +54.37% | 11 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $60 → $55 | $35.71 | +54.02% | 13 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $8.5 | $6.60 | +28.79% | 8 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $57 | $36.07 | +58.05% | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $160 | $75.25 | +112.62% | 1 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $113.65 | - | 9 | Dec 14, 2020 |
The Chemours Company
May 12, 2025
Maintains: Equal-Weight
Price Target: $22 → $15
Current: $9.93
Upside: +51.06%
Corteva
May 9, 2025
Maintains: Overweight
Price Target: $65 → $71
Current: $69.50
Upside: +2.16%
Axalta Coating Systems
May 8, 2025
Maintains: Equal-Weight
Price Target: $40 → $36
Current: $30.99
Upside: +16.17%
Albemarle
May 6, 2025
Maintains: Underweight
Price Target: $68 → $58
Current: $56.97
Upside: +1.81%
Tronox Holdings
May 5, 2025
Maintains: Equal-Weight
Price Target: $12 → $8
Current: $4.87
Upside: +64.44%
DuPont de Nemours
May 5, 2025
Maintains: Equal-Weight
Price Target: $94 → $80
Current: $68.19
Upside: +17.32%
Eastman Chemical Company
Apr 28, 2025
Maintains: Overweight
Price Target: $125 → $115
Current: $80.65
Upside: +42.59%
The Sherwin-Williams Company
Apr 22, 2025
Maintains: Overweight
Price Target: $405 → $385
Current: $353.31
Upside: +8.97%
CF Industries Holdings
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $85 → $80
Current: $89.30
Upside: -10.41%
Bunge Global
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $90 → $74
Current: $78.66
Upside: -5.92%
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $52 → $47
Current: $48.02
Upside: -2.12%
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $70 → $46
Current: $39.34
Upside: +16.93%
Feb 4, 2025
Maintains: Overweight
Price Target: $90 → $85
Current: $56.91
Upside: +49.36%
Jan 31, 2025
Maintains: Equal-Weight
Price Target: $46 → $43
Current: $28.27
Upside: +52.10%
Jan 28, 2025
Upgrades: Overweight
Price Target: $263 → $280
Current: $262.50
Upside: +6.67%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $100 → $80
Current: $53.42
Upside: +49.76%
Jun 5, 2024
Maintains: Equal-Weight
Price Target: $240 → $280
Current: $269.97
Upside: +3.72%
Aug 1, 2023
Reiterates: Overweight
Price Target: $420
Current: $461.04
Upside: -8.90%
Jul 24, 2023
Maintains: Equal-Weight
Price Target: $143 → $155
Current: $110.20
Upside: +40.65%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $100 → $91
Current: $58.95
Upside: +54.37%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $60 → $55
Current: $35.71
Upside: +54.02%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $12 → $8.5
Current: $6.60
Upside: +28.79%
May 12, 2021
Maintains: Equal-Weight
Price Target: $45 → $57
Current: $36.07
Upside: +58.05%
Apr 12, 2021
Reinstates: Overweight
Price Target: $160
Current: $75.25
Upside: +112.62%
Dec 14, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $113.65
Upside: -